Biotech Values

[jbog]

Dew,

Moreover, the proprietary pharma successor company will derive about 50% of its profits from one drug: Humira. It will be the biggest-selling drug in the world (#msg-64677120), but it’s still only one drug, which is an inordinate amount of concentration for a company that is expected to have about $20B in annual sales.

That is exactly WHY they would want to distance themselves from pharma.



As a second point, these guys aren't currently being paid from the EU. Spanish local governments haven't paid their bills in over a year, and they are playing chicken with big Pharma to see if they get cut off. ((Spain’s regional governments owe 5.4 billion euros for medicines supplied to hospitals and are paying bills an average of 430 days late, Arnes said. That debt, as at June 30, increased from 5.19 billion euros at the end of March, when the average delay was 410 days, according to the group’s statistics.))